living the budlife
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
SGMD WORLDS LARGEST PUBLIC HEMP COMPANY
SOON REITERATE 70 MILLION IN PROFITS
PER 10K BUDLIFE DELIVERIES BY 12/31/18
ANYTHING UNDER .15 ARE CHEAPIES
BIZRIGHT DEAL FINALLY CLOSED
APPEARS FILING 10Q FRIDAY
Attention: We are now serving Kung Pao Dog in the SGMD Cafeteria
SGMD TO PURCHASE ENTIRE STATE OF KENTUCKY FOR IT'S HEMP DIVISION
SUGARMADE RETURNS TO THE OTCQB AS FULLY REPORTING-CEO NO FACE COMMENTS ON GROWTH
SUGARMADE RETURNS TO THE OTCQB AS FULLY REPORTING-CEO NO FACE COMMENTS ON GROWTH
Monrovia, CA -- August 8, 2018 -- InvestorsHub NewsWire -- Sugarmade, Inc. (OTC:SGMD), one of the largest publicly traded cannabis-related hydroponics supply companies returns to the OTCQB Venture Market trading venue as a fully reporting company with the U.S. Securities & Exchange Commission. Additionally, the Company makes comments relative to the strong revenue growth it is experiencing within the cannabis supplies marketplace.
Sugarmade expects revenue growth to at least $30 million for 2019, with operating profitability and positive operating cash flow. For the most recently reported quarter, the Company reported revenues of just under $3 million, representing a sequential revenue increase of approximately 215% and a year over year revenue increase of approximately 228%. The Company is expecting additional revenue growth over the coming quarters due to a significant increase in the number of products being offered for sale and due to continued strong momentum in cannabis cultivation in California and other U.S. states where legalization has occurred.
NO FACE, CEO of Sugarmade commented, "We are very proud of the growth we are realizing. A year ago we had a staff of 22 packed into a small office and warehouse. We have now grown our staff to more than 45, with additional staff member recruitment underway, and our office and warehouse space has increased by more than 300%. Our new facility in Monrovia, Ca, will allow us to grow our revenue to our stated objective of at least $30 million for next year. All of us at Sugarmade thank our valued shareholders for all the support provided as we grow our organization to address what we believe is one of the most exciting business marketplaces seen over the past few decades."
About Sugarmade, Inc. (OTC:SGMD):
Sugarmade, Inc. is a product and brand marketing company investing in products and brands with disruptive potential. Sugarmade's brands include ZenHydro.com, CarryOutSupplies.com, and BudLife Cannabis Storage Solutions. For more information on the Company's products, please visit http://www.Sugarmade.com.
For inquiries please contact Jimmy Chan at (888) 982-1628 or info@Sugarmade.com.
FORWARD-LOOKING STATEMENTS: This release contains "forward-looking statements" within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements also may be included in other publicly available documents issued by the Company and in oral statements made by our officers and representatives from time to time. These forward-looking statements are intended to provide management's current expectations or plans for our future operating and financial performance, based on assumptions currently believed to be valid. They can be identified by the use of words such as "anticipate," "intend," "plan," "goal," "seek," "believe," "project," "estimate," "expect," "strategy," "future," "likely," "may," "should," "would," "could," "will" and other words of similar meaning in connection with a discussion of future operating or financial performance. Examples of forward looking statements include, among others, statements relating to future sales, earnings, cash flows, results of operations, uses of cash and other measures of financial performance.
WHERE'S THE 10 Q ?
NO TIKEE NO WASHEE HERE
•Q1 2019 revenue for the Company was $1.68 million, an increase of 862 per cent from Q1 2018 and a 227 per cent increase from the previous quarter. This increase is primarily due to the contribution of Dream Water sales, bulk sales of cannabis to other Licensed Producers, and an initial recreational cannabis sale to the Province of British Columbia.
•As of September 30, 2018, the Company maintains a very strong balance sheet with a cash balance of $48.3 million. This cash position means all current expansion plans are fully funded and allows for further acquisitions that support the Company’s brand and product development strategy.
•The Company signed agreements to supply adult-use cannabis with four provinces: British Columbia, Ontario, Manitoba and Saskatchewan. The Company successfully met all provincial load-in obligations.
•The Company also initiated its retail strategy acquiring a 19.99 per cent interest in a luxury BC-based retail group called Burb Cannabis Corp. (“Burb”). The investment falls within the allowable maximum investment of 20 per cent established by the BC Government. Burb expects to open between eight to 10 stores in BC in 2019, with a further roll out across the country.
•The Company announced favourable results in Phase 2 clinical trials using its proprietary Satipharm capsules for the treatment of pediatric epilepsy. The median seizure reduction was -82 per cent in the 12-week treatment period. These results were recently presented at the Epilepsy Society of Australia Conference.
•The Company closed a strategic acquisition of Phytotech Therapeutics (“PTL”) giving the Company access to valuable IP and research capabilities to support product development for Satipharm.
•The Company entered into a multi-year Extraction Services Agreement with Valens GroWorks Corp. (“Valens”) for cannabis extraction and value-added services. The Company intends to work very closely with Valens to develop innovative products to support both its recreational and medical strategies.
•The Company has started construction on two separate expansion sites - one in British Columbia and the other in Saskatchewan. In Duncan, BC the Company’s facility is undergoing a modular expansion which will triple output as the modules come online. The first harvest is scheduled for early 2019. At the Company’s Lucky Lake facility in Saskatchewan construction is underway on a state-of-the-art indoor cultivation facility which will produce an estimated 8,000+ kgs of the Company’s premium-quality dried flower product annually.
Fiscal 2019 started with the appointment of a new CEO Grant Froese. Mr. Froese comes to Harvest One with 38 years retail and operations experience, most recently as Chief Operating Officer of Loblaw. In addition to this appointment, Harvest One underwent a significant overhaul of the senior leadership team, making the following notable additions:
.30 A SHARE BABY! HRVOF
Andrew Kain Chief Operating Officer and General Counsel
David Hyde Advisory Board
Frank Holler Board of Directors
Will Stewart SVP Corporate and Public Affairs
Ann Gallery SVP Corporate Communications
Gord Davey SVP Global Sales
Todd Dea President of United Greeneries
Jonathan Hartshorn President of Satipharm
Tucker Wright President of Dream Water
For more information on the team, please visit Harvest One’s Management page.
Harvest One’s 2019 first quarter MD&A and consolidated financial statements for the quarter ended September 30, 2018, along with all previous Harvest One public filings, may be found on SEDAR at www.SEDAR.com.
About Harvest One Cannabis Inc. (TSXV: HVT)
Harvest One is a global cannabis company that develops and provides innovative lifestyle and wellness products to consumers and patients in regulated markets around the world. The Company's range of lifestyle solutions is designed to enhance quality of life. Shareholders have significant exposure to the entire cannabis value chain through three wholly-owned subsidiaries; United Greeneries, a Licensed Producer; Satipharm (medical and nutraceutical); and Dream Water Global (consumer); and a minority interest in Burb Cannabis (retail operations). For more information, please visit www.harvestone.com.
For more information, please contact:
NO FACE CEO PEE ON SHAREHOLDER MEETING
SORRY BIZRIGHT NOT HAPPENING PEOPLE
7 EMPLOYEES AND 6 MILLION LOSS
PAPER CUPS AND 6 MILLION LOSS
.40 NEXT WEEK
VOLUME LOOKING GOOD
I WILL BUY ANY .0975s FOR SALE
FILL YOUR BAGS WITH HRVOF
UPLISTING SOON!
"cAN cHAn bLOW 2 deals In 1 year " sylvestor the accredited investor
"so I can buy em back @ .09" sylvestor the accredited invesor
"come and get my 600,000 !" sylvestor the accredited investor
"see you at the next shareholder meeting" sylvestor the accredited investor
Harvest One pleased to announce record revenues for first quarter of fiscal 2019
HRVOF
7:55 PM ET 11/29/18 | Dow Jones
Harvest One pleased to announce record revenues for first quarter of fiscal 2019
Canada NewsWire
TORONTO, Nov. 29, 2018
TSXV -- HVT
TORONTO, Nov. 29, 2018 /CNW/ - Harvest One Cannabis Inc. (TSXV:HVT) ("Harvest One" or the "Company") today announced the release of its financial and operating results for the three months ended September 30, 2018.
"This has been an exciting and decisive period in the history of Harvest One," said Grant Froese, CEO of Harvest One. "Harvest One has undergone important leadership changes as it transitions to the next stage of its development. This quarter was also a pivotal period in the evolution of the Canadian Cannabis industry as all stakeholders underwent the unique operational exercise of preparing for full legalization of recreational cannabis in Canada. I am proud to say Harvest One has executed on our roll-out strategy, meeting all provincial obligations and establishing the basis for successful long-term relationships with both public and private retailers. The work we are doing now lays the foundation for a landmark year in 2019 when cannabis companies will be judged on execution and financial performance. This is emphasized by Harvest One's record revenues this quarter, representing an 862 per cent increase over the same period last year. With revenue forecasts in place for each of our four divisions -- licensed producer, retail, medical & nutraceutical, and consumer - Harvest One remains very optimistic for the balance of fiscal 2019."
Highlights:
-- Q1 2019 revenue for the Company was $1.68 million, an increase of 862 per
cent from Q1 2018 and a 227 per cent increase from the previous quarter.
This increase is primarily due to the contribution of Dream Water sales,
bulk sales of cannabis to other Licensed Producers, and an initial
recreational cannabis sale to the Province of British Columbia.
-- As of September 30, 2018, the Company maintains a very strong balance
sheet with a cash balance of $48.3 million. This cash position means all
current expansion plans are fully funded and allows for further
acquisitions that support the Company's brand and product development
strategy.
-- The Company signed agreements to supply adult-use cannabis with four
provinces: British Columbia, Ontario, Manitoba and Saskatchewan. The
Company successfully met all provincial load-in obligations.
-- The Company also initiated its retail strategy acquiring a 19.99 per cent
interest in a luxury BC-based retail group called Burb Cannabis Corp.
("Burb"). The investment falls within the allowable maximum investment of
20 per cent established by the BC Government. Burb expects to open
between eight to 10 stores in BC in 2019, with a further roll out across
the country.
-- The Company announced favourable results in Phase 2 clinical trials using
its proprietary Satipharm capsules for the treatment of pediatric
epilepsy. The median seizure reduction was -82 per cent in the 12-week
treatment period. These results were recently presented at the Epilepsy
Society of Australia Conference.
-- The Company closed a strategic acquisition of Phytotech Therapeutics
("PTL") giving the Company access to valuable IP and research
capabilities to support product development for Satipharm.
-- The Company entered into a multi-year Extraction Services Agreement with
Valens GroWorks Corp. ("Valens") for cannabis extraction and value-added
services. The Company intends to work very closely with Valens to develop
innovative products to support both its recreational and medical
strategies.
-- The Company has started construction on two separate expansion sites -
one in British Columbia and the other in Saskatchewan. In Duncan, BC the
Company's facility is undergoing a modular expansion which will triple
output as the modules come online. The first harvest is scheduled for
early 2019. At the Company's Lucky Lake facility in Saskatchewan
construction is underway on a state-of-the-art indoor cultivation
facility which will produce an estimated 8,000+ kgs of the Company's
premium-quality dried flower product annually.
Fiscal 2019 started with the appointment of a new CEO Grant Froese. Mr. Froese comes to Harvest One with 38 years retail and operations experience, most recently as Chief Operating Officer of Loblaw. In addition to this appointment, Harvest One underwent a significant overhaul of the senior leadership team, making the following notable additions:
Andrew Kain Chief Operating Officer and General Counsel
David Hyde Advisory Board
Frank Holler Board of Directors
Will Stewart SVP Corporate and Public Affairs
Ann Gallery SVP Corporate Communications
Gord Davey SVP Global Sales
Todd Dea President of United Greeneries
Jonathan Hartshorn President of Satipharm
Tucker Wright President of Dream Water
For more information on the team, please visit Harvest One's Management page.
Harvest One's 2019 first quarter MD&A and consolidated financial statements for the quarter ended September 30, 2018, along with all previous Harvest One public filings, may be found on SEDAR at www.SEDAR.com.
About Harvest One Cannabis Inc. (TSXV: HVT)
Harvest One is a global cannabis company that develops and provides innovative lifestyle and wellness products to consumers and patients in regulated markets around the world. The Company's range of lifestyle solutions is designed to enhance quality of life. Shareholders have significant exposure to the entire cannabis value chain through three wholly-owned subsidiaries; United Greeneries, a Licensed Producer; Satipharm (medical and nutraceutical); and Dream Water Global (consumer); and a minority interest in Burb Cannabis (retail operations). For more information, please visit www.harvestone.com.
This press release contains "forward-looking statements,"which may be identified by the use of words such as, "may," "would," "could," "will," "likely," "expect," "anticipate," "believe," "intend," "plan," "forecast, " "project," "estimate," "outlook"and other similar expressions, including statements regarding our growth potential, the sustainability of growth, completion of construction at the BC and Saskatchewan expansion sites, output and production estimates at the BC and Saskatchewan expansion sites, development of new products, demand for our products and the medical and recreational cannabis markets. Forward-looking statements are not a guarantee of future performance and are based upon a number of estimates and assumptions of management in light of management's experience and perception of trends, current conditions and expected developments, as well as other factors that management believes to be relevant and reasonable in the circumstances, including assumptions in respect of current and future market conditions. Actual results, performance or achievement could differ materially from that expressed in, or implied by, any forward-looking statements in this press release, and, accordingly, you should not place undue reliance on any such forward-looking statements and they are not guarantees of future results. Forward-looking statements involve significant risks, assumptions, uncertainties and other factors that may cause actual future results or anticipated events to differ materially from those expressed or implied in any forward-looking statements. Please see the heading "Risk Factors" in our 2019 first quarter MD&A which was filed on SEDAR on November 29, 2018 for a discussion of the material risk factors that could cause actual results to differ materially from the forward-looking information. The Company does not undertake to update any forward-looking statements that are included herein, except in accordance with applicable securities laws.
Neither TSX-V nor its Regulation Services Provider (as that term is defined in the policies of the TSX-V) accept responsibility for the adequacy or accuracy of this release.
SOURCE Harvest One Cannabis Inc.
View original content to download multimedia: http://www.newswire.ca/en/releases/archive/November2018/29/c4061.html
/CONTACT:
Investor Relations: Colin Clancy, + 1 (877) 915-7934, cclancy@harvestone.com; Media Relations: Ann Gallery, + 1 (604) 322-5897, agallery@harvestone.com
Copyright CNW Group 2018
> Dow Jones Newswires
November 29, 2018 19:55 ET (00:55 GMT)
Harvest One pleased to announce record revenues for first quarter of fiscal 2019
7:55 PM ET 11/29/18 | Dow Jones
Harvest One pleased to announce record revenues for first quarter of fiscal 2019
Canada NewsWire
TORONTO, Nov. 29, 2018
TSXV -- HVT
TORONTO, Nov. 29, 2018 /CNW/ - Harvest One Cannabis Inc. (TSXV:HVT) ("Harvest One" or the "Company") today announced the release of its financial and operating results for the three months ended September 30, 2018.
"This has been an exciting and decisive period in the history of Harvest One," said Grant Froese, CEO of Harvest One. "Harvest One has undergone important leadership changes as it transitions to the next stage of its development. This quarter was also a pivotal period in the evolution of the Canadian Cannabis industry as all stakeholders underwent the unique operational exercise of preparing for full legalization of recreational cannabis in Canada. I am proud to say Harvest One has executed on our roll-out strategy, meeting all provincial obligations and establishing the basis for successful long-term relationships with both public and private retailers. The work we are doing now lays the foundation for a landmark year in 2019 when cannabis companies will be judged on execution and financial performance. This is emphasized by Harvest One's record revenues this quarter, representing an 862 per cent increase over the same period last year. With revenue forecasts in place for each of our four divisions -- licensed producer, retail, medical & nutraceutical, and consumer - Harvest One remains very optimistic for the balance of fiscal 2019."
Highlights:
-- Q1 2019 revenue for the Company was $1.68 million, an increase of 862 per
cent from Q1 2018 and a 227 per cent increase from the previous quarter.
This increase is primarily due to the contribution of Dream Water sales,
bulk sales of cannabis to other Licensed Producers, and an initial
recreational cannabis sale to the Province of British Columbia.
-- As of September 30, 2018, the Company maintains a very strong balance
sheet with a cash balance of $48.3 million. This cash position means all
current expansion plans are fully funded and allows for further
acquisitions that support the Company's brand and product development
strategy.
-- The Company signed agreements to supply adult-use cannabis with four
provinces: British Columbia, Ontario, Manitoba and Saskatchewan. The
Company successfully met all provincial load-in obligations.
-- The Company also initiated its retail strategy acquiring a 19.99 per cent
interest in a luxury BC-based retail group called Burb Cannabis Corp.
("Burb"). The investment falls within the allowable maximum investment of
20 per cent established by the BC Government. Burb expects to open
between eight to 10 stores in BC in 2019, with a further roll out across
the country.
-- The Company announced favourable results in Phase 2 clinical trials using
its proprietary Satipharm capsules for the treatment of pediatric
epilepsy. The median seizure reduction was -82 per cent in the 12-week
treatment period. These results were recently presented at the Epilepsy
Society of Australia Conference.
-- The Company closed a strategic acquisition of Phytotech Therapeutics
("PTL") giving the Company access to valuable IP and research
capabilities to support product development for Satipharm.
-- The Company entered into a multi-year Extraction Services Agreement with
Valens GroWorks Corp. ("Valens") for cannabis extraction and value-added
services. The Company intends to work very closely with Valens to develop
innovative products to support both its recreational and medical
strategies.
-- The Company has started construction on two separate expansion sites -
one in British Columbia and the other in Saskatchewan. In Duncan, BC the
Company's facility is undergoing a modular expansion which will triple
output as the modules come online. The first harvest is scheduled for
early 2019. At the Company's Lucky Lake facility in Saskatchewan
construction is underway on a state-of-the-art indoor cultivation
facility which will produce an estimated 8,000+ kgs of the Company's
premium-quality dried flower product annually.
Fiscal 2019 started with the appointment of a new CEO Grant Froese. Mr. Froese comes to Harvest One with 38 years retail and operations experience, most recently as Chief Operating Officer of Loblaw. In addition to this appointment, Harvest One underwent a significant overhaul of the senior leadership team, making the following notable additions:
Andrew Kain Chief Operating Officer and General Counsel
David Hyde Advisory Board
Frank Holler Board of Directors
Will Stewart SVP Corporate and Public Affairs
Ann Gallery SVP Corporate Communications
Gord Davey SVP Global Sales
Todd Dea President of United Greeneries
Jonathan Hartshorn President of Satipharm
Tucker Wright President of Dream Water
For more information on the team, please visit Harvest One's Management page.
Harvest One's 2019 first quarter MD&A and consolidated financial statements for the quarter ended September 30, 2018, along with all previous Harvest One public filings, may be found on SEDAR at www.SEDAR.com.
About Harvest One Cannabis Inc. (TSXV: HVT)
Harvest One is a global cannabis company that develops and provides innovative lifestyle and wellness products to consumers and patients in regulated markets around the world. The Company's range of lifestyle solutions is designed to enhance quality of life. Shareholders have significant exposure to the entire cannabis value chain through three wholly-owned subsidiaries; United Greeneries, a Licensed Producer; Satipharm (medical and nutraceutical); and Dream Water Global (consumer); and a minority interest in Burb Cannabis (retail operations). For more information, please visit www.harvestone.com.
This press release contains "forward-looking statements,"which may be identified by the use of words such as, "may," "would," "could," "will," "likely," "expect," "anticipate," "believe," "intend," "plan," "forecast, " "project," "estimate," "outlook"and other similar expressions, including statements regarding our growth potential, the sustainability of growth, completion of construction at the BC and Saskatchewan expansion sites, output and production estimates at the BC and Saskatchewan expansion sites, development of new products, demand for our products and the medical and recreational cannabis markets. Forward-looking statements are not a guarantee of future performance and are based upon a number of estimates and assumptions of management in light of management's experience and perception of trends, current conditions and expected developments, as well as other factors that management believes to be relevant and reasonable in the circumstances, including assumptions in respect of current and future market conditions. Actual results, performance or achievement could differ materially from that expressed in, or implied by, any forward-looking statements in this press release, and, accordingly, you should not place undue reliance on any such forward-looking statements and they are not guarantees of future results. Forward-looking statements involve significant risks, assumptions, uncertainties and other factors that may cause actual future results or anticipated events to differ materially from those expressed or implied in any forward-looking statements. Please see the heading "Risk Factors" in our 2019 first quarter MD&A which was filed on SEDAR on November 29, 2018 for a discussion of the material risk factors that could cause actual results to differ materially from the forward-looking information. The Company does not undertake to update any forward-looking statements that are included herein, except in accordance with applicable securities laws.
Neither TSX-V nor its Regulation Services Provider (as that term is defined in the policies of the TSX-V) accept responsibility for the adequacy or accuracy of this release.
SOURCE Harvest One Cannabis Inc.
View original content to download multimedia: http://www.newswire.ca/en/releases/archive/November2018/29/c4061.html
/CONTACT:
Investor Relations: Colin Clancy, + 1 (877) 915-7934, cclancy@harvestone.com; Media Relations: Ann Gallery, + 1 (604) 322-5897, agallery@harvestone.com
Copyright CNW Group 2018
> Dow Jones Newswires
November 29, 2018 19:55 ET (00:55 GMT)
WERE GETTING IN ON THE BASEMENT
"It's like striking GOLD" sylvestor the accredited investor
"SGMD world's largest Hemp Company" sylvestor the accredited investor
"turn $100,000 to $300,000" sylvestor the accredited investor
"reiterate .30 target" sylvestor the accredited investor
"Get a loan and buy more !" sylvestor the accredited investor
"Jump in It !" syslvestor the accredited investor
"SGMD AQUISITION POWERHOUSE" sylvestor the accredited investor
"let's see that beautiful 10q !" sylvestor the accredited investor
Green Again Today :)
GONNA BE BEST 10 q EVER !
sgmd STAYING GREEN TOMORROW !
RAT a g down 20% today